Hypothesis Comparison

⚛ Collide these ⚔ Judge as Duel

Comparing 2 hypotheses side-by-side

|

c-Abl Tyrosine Kinase Activation Drives α-Synuclein Phosphorylation and Neurodeg

ABL1 · neurodegeneration · -
Composite
0.605
Price
$0.61
Evidence For
0
Evidence Against
0

c-Abl (ABL1) phosphorylates α-synuclein at Y39, promoting aggregation and neuronal toxicity. Nilotinib (FDA-approved for CML) inhibits c-Abl and promotes α-syn clearance via autophagy, representing a rapid translational candidate. However, the hypothesis faces significant challenges: (1) Y39 phosphorylation is less abundant than S129 in human synucleinopathies and its aggregation role is contested; (2) Nilotinib failed its primary endpoint in PD clinical trials (Ko et al. 2020) with no UPDRS imp

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinflammation

TREM2 · neurodegeneration · mechanistic
Composite
0.000
Price
$0.00
Evidence For
0
Evidence Against
0

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinflammation proposes that TREM2 dysfunction disrupts critical intercellular communication networks between microglia and astrocytes, leading to pathological neuroinflammation in neurodegenerative diseases. Under normal conditions, TREM2 signaling in microglia promotes the release of anti-inflammatory mediators including IL-10, TGF-β, and specialized pro-resolving mediators (SPMs) that maintain astrocytes in a homeostatic A2-like state. TREM

Convergent vs Divergent Predictions

This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.

AutophagyNeuroinflammationneurodegeneration
Convergent signals
  • No same-target convergence detected in this selection.
Divergent signals
  • No direct polarity conflicts detected among the selected hypotheses.

Verdict Summary

8/11
dimensions won
c-Abl Tyrosine Kinase Activation Drives
4/11
dimensions won
TREM2-Dependent Astrocyte-Microglia Cros

Radar Chart — 10 Dimensions

Score Comparison Bars

Mechanistic
0.58
0.62
Evidence
0.68
0.00
Novelty
0.60
0.00
Feasibility
0.55
0.00
Impact
0.52
0.00
Druggability
0.70
0.45
Safety
0.50
0.58
Competition
0.60
0.50
Data
0.72
0.52
Reproducible
0.60
0.60
KG Connect
0.50
0.91

Score Breakdown

Dimensionc-Abl Tyrosine Kinase ActivatiTREM2-Dependent Astrocyte-Micr
Mechanistic0.5800.620
Evidence0.6800.000
Novelty0.6000.000
Feasibility0.5500.000
Impact0.5200.000
Druggability0.7000.450
Safety0.5000.580
Competition0.6000.500
Data0.7200.520
Reproducible0.6000.600
KG Connect0.5000.911

Evidence

c-Abl Tyrosine Kinase Activation Drives α-Synuclein Phosphor

No evidence citations yet

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinfla

No evidence citations yet

Debate Excerpts

c-Abl Tyrosine Kinase Activation Drives α-Synuclei

4 rounds · quality: 0.81

Theorist

# Legacy Pre-Pipeline Hypotheses: Neurodegeneration --- ## Hypothesis 1: Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disease **Mechanism:** Misfolded α-synuclein (aSy...

Skeptic

# Critical Evaluation of Legacy Pre-Pipeline Hypotheses ## General Methodological Concerns (Cross-Cutting Issues) Before evaluating individual hypotheses, several systemic weaknesses affect the enti...

Domain Expert

# Comprehensive Feasibility Assessment: Legacy Neurodegeneration Hypotheses ## Preamble This assessment evaluates each hypothesis across five critical domains using a standardized framework. Evidenc...

Synthesizer

```json { "ranked_hypotheses": [ { "title": "TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease", "description": "TREM2 loss-of-function variants ...

Price History Overlay

Knowledge Graph Comparison

c-Abl Tyrosine Kinase Activation Drives

0 edges
Top Node Types
Top Relations

TREM2-Dependent Astrocyte-Microglia Cros

23 edges
Top Node Types
mechanism8
gene7
protein6
pathway1
brain_region1
Top Relations
causes3
precedes3
correlates_with2
associated_with2
facilitates2